期刊
SCIENCE
卷 338, 期 6109, 页码 903-910出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1226338
关键词
-
资金
- NIH National Institute of Biomedical Imaging and Bioengineering (NIBIB) [R01-EB012065]
- National Cancer Institute [R01-CA157766]
- NIBIB [R21-EB013226, R21-EB013754]
- National Heart, Lung, and Blood Institute [RO1 HL087036]
Nanoparticle-based drug delivery systems have been developed to improve the efficacy and reduce the systemic toxicity of a wide range of drugs. Although clinically approved nanoparticles have consistently shown value in reducing drug toxicity, their use has not always translated into improved clinical outcomes. This has led to the development of multifunctional nanoparticles, where additional capabilities like targeting and image contrast enhancement are added to the nanoparticles. However, additional functionality means additional synthetic steps and costs, more convoluted behavior and effects in vivo, and also greater regulatory hurdles. The trade-off between additional functionality and complexity is the subject of ongoing debate and the focus of this Review.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据